Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Alkermes
Company Monitoring Page for Alkermes
latest headlines for company on cafepharma
Alkermes Announces Restructuring Plan
Yahoo/Zacks
Fri, 04/12/13 - 09:52 am
Tags:
restructuring
,
Alkermes
Alkermes Turns to Profit, Ups View
Yahoo/Zacks
Fri, 02/1/13 - 11:01 am
Tags:
earnings
,
Alkermes
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds
Xconomy
Mon, 01/7/13 - 10:38 am
Tags:
Alkermes
,
Eli Lilly
,
schizophrenia
,
ALKS33
,
Zyprexa
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Fri, 07/27/12 - 11:55 am
Tags:
Vivus
,
Biomarin
,
Alkermes
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
Tags:
drug approvals
,
earnings
,
Amylin
,
InterMune
,
Human Genome Sciences
,
GSK
,
Bristol-Myers Squibb
,
Questcor
,
BiogenIdec
,
Alexion
,
Regeneron
,
Eli Lilly
,
Amarin
,
Horizon Pharma
,
Celgene
,
Amgen
,
Gilead
,
Alkermes
,
United Therapeutics
,
Roche
,
Sanofi
,
Merck
,
AstraZeneca
,
Salix
,
Progenics Pharmaceuticals
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Tags:
Pluristem Therapeutics
,
Alkermes
,
AstraZeneca
,
Bristol-Myers Squibb
,
Isis Pharmaceuticals
,
Eli Lilly
,
Momenta
,
Merck
,
Pfizer
,
Sanofi
,
Spectrum Pharmaceuticals
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Tags:
Alkermes
,
Medivation
,
Cubist Pharmaceuticals
,
Ariad Pharmaceuticals
,
Questcor Pharmaceuticals
,
Arena Pharmaceuticals
,
Seattle Genetics
,
Incyte
,
United Therapeutics
,
Amarin
,
ONYX Pharmaceuticals
,
Pharmacyclics
,
Human Genome Sciences
,
Theravance
Questcor: Why Analysts Are Improving Its Ratings Now
Seeking Alpha
Thu, 07/12/12 - 10:58 am
Tags:
Questcor
,
Alkermes
,
Arena Pharmaceuticals
,
Vivus
,
Orexigen
Pipeline Progress at Alkermes/JNJ
Yahoo/Zacks
Wed, 06/13/12 - 11:48 am
Tags:
JNJ
,
Alkermes
,
Invega Sustenna
,
Janssen
,
schizophrenia
Vivus Poised For $5 Jump In 12 Months
Seeking Alpha
Tue, 06/12/12 - 01:11 pm
Tags:
Vivus
,
Alkermes
,
Questcor
,
Orexigen
,
Arena Pharmaceuticals
Monday's Bio Pharma Momentum Movers And Buy-Out Speculation List
Seeking Alpha
Mon, 06/11/12 - 11:26 am
Tags:
Alkermes
,
Amylin
,
Arena Pharmaceuticals
,
GSK
,
Human Genome Sciences
,
Obagi Medical Products
Once-Weekly Bydureon Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:34 pm
Tags:
type 2 diabetes
,
diabetes
,
Bydureon
,
Amylin
,
Alkermes
Bydureon Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:33 pm
Tags:
Bydureon
,
type 2 diabetes
,
Amylin
,
Alkermes
,
diabetes
Elan to bank $381 million from sale of Alkermes stock
Pharma Times, UK
Wed, 03/14/12 - 09:45 am
Tags:
Alkermes
,
Elan
Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tue, 02/21/12 - 07:19 pm
Tags:
obesity
,
Vivus
,
Qnexa
,
Abbott Laboratories
,
Alkermes
,
GSK
,
JNJ
,
Roche
,
Orexigen
FDA nod fuels Bydureon vs. Victoza bout
Fierce Pharma
Mon, 01/30/12 - 04:00 pm
Tags:
Victoza
,
diabetes
,
Bydureon
,
FDA
,
Amylin
,
Novo Nordisk
,
Alkermes
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Bloomberg
Fri, 01/27/12 - 03:12 pm
Tags:
Amylin
,
FDA
,
Alkermes
,
diabetes
,
Bydureon
Sector Snap: Specialty drugs in 2012
BusinessWeek
Sun, 01/8/12 - 12:58 pm
Tags:
Salix
,
Cubist Pharmaceuticals
,
Ironwood Pharmaceuticals
,
Emergent BioSolutions
,
Xifaxin
,
Cubicin
,
Alkermes
,
Questcor Pharmaceuticals
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Tags:
Oncothyreon
,
Keryx
,
Vical
,
Aeterna Zentaris
,
Eli Lilly
,
JNJ
,
Elan
,
Celgene
,
Pfizer
,
Gilead
,
Pharmasset
,
Threshold Pharmaceuticals
,
Celldex
,
Amgen
,
BioVex
,
Aveo Pharmaceutical
,
Amylin
,
Alkermes
,
Vertex
,
Cell Therapeutics
,
Amarin
,
ONYX Pharmaceuticals
,
Vivus
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Date
Seeking Alpha
Tue, 12/6/11 - 09:21 am
Tags:
Alkermes
,
Amylin
,
Antares
,
AstraZeneca
,
Bristol-Myers Squibb
,
Merck
,
Eli Lilly
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.